Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-24 @ 12:46 PM
NCT ID:
NCT06672861
Eligibility Criteria:
Inclusion criteria:
Patients with a Diagnosis of POTS, IST, or vasovagal syncope
Exclusion criteria:
Patients with comorbid chronic conditions causing significant impairments in quality of life, defined as:
* NYHA Class III or IV Heart Failure
* COPD GOLD 3 or 4, Group C or D
* Any patients with current malignancy not in remission
* Any patient with history of Autoimmune disease requiring chronic steroid therapy or immunomodulatory agents: Rheumatoid Arthritis, Lupus, Sarcoidosis, Psoriasis All patients with ESRD requiring hemodialysis All patients with cirrhosis of any origin Any patients with solid organ or bone marrow transplant requiring immunosuppressive therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06672861
Study Brief:
Protocol Section:
NCT06672861